Intuitive Surgical
Open
$452.48
Prev. Close
$452.48
High
$452.48
Low
$452.27
Market Snapshot
$161.17B
54.1
6.54
$8.35B
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 17,021 full-time employees. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
emptyResult
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 17,021 full-time employees. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Recently from Cashu
Intuitive Surgical Prioritizes Patient Safety by Removing Risky Staplers Following FDA Guidance
Intuitive Surgical Takes Proactive Measures in Patient Safety Amidst FDA Guidance Intuitive Surgical, a leader in robotic-assisted surgical systems, has promptly notified customers about the removal o…
Intuitive Surgical Takes Action on Stapler Safety to Ensure Patient Protection and Compliance
Intuitive Surgical Proactively Addresses Stapler Safety Concerns Intuitive Surgical, a leader in robotic-assisted surgical systems, issues a vital notification to its customers regarding the immediate…
Intuitive Surgical Addresses Cybersecurity Threats After Phishing Attack Compromises Employee Account
Intuitive Surgical Faces Cybersecurity Challenge Amid Phishing Attack Intuitive Surgical is currently addressing a significant cybersecurity incident stemming from a targeted phishing attack that comp…
Intuitive Surgical: Leading Innovation in Robotic Surgery Amid Shifting Investor Sentiment
Recent Shifts in Investor Sentiment: A Focus on Intuitive Surgical’s Innovation in Robotic Surgery In the evolving landscape of healthcare technology, Intuitive Surgical stands out as a company commit…